The volumes of the main components of the diencephalon from 10 basal insectivores, 12 prosimians, and 15 simians including man were compared. The comparison of the percentage composition within the diencephalon shows that the thalamus and the subthalamus increase whereas the epithalamus and the hypothalamus decrease in relative size among primates. The allometric analysis reveals that, in spite of a relative reduction, the epithalamus and the hypothalamus are also progressive structures. However, their allometric size increase, being especially accentuated in earlier phyletic phases, is small in comparison to that of the thalamus and the subthalamus. These latter two components are characterized by a continuous phylogenetic growth from the basal insectivores to the simians. The correlation analysis shows that the strongest correlations and, in many cases, that isometric size increase exist between structures which belong to the same functional system.These findings indicate the existence of at least two major developmental gradients in the quantitative development of the diencephalon, a neencephalic and a limbic one.

Keywords:
Morphometry, Diencephalon, Mammals, Evolution
This content is only available via PDF.
© 1979 S. Karger AG, Basel
1979
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.